ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SVA Sinovac Biotech Ltd

6.47
0.00 (0.00%)
After Hours
Last Updated: 10:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Sinovac Biotech Ltd SVA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 6.47 10:00:00
Open Price Low Price High Price Close Price Previous Close
6.47 6.47
more quote information »

Recent News

Date Time Source Heading
30/4/202407:53BWSINOVAC Reports Unaudited Second Half of 2023 Financial..
21/2/202422:09EDGAR2Form 8-A12B/A - Registration of securities [Section 12(b)]:..
21/2/202422:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/2/202418:56BWSinovac Amends Shareholder Rights Plan
03/2/202403:19EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
19/1/202422:58BWシノバック取締役会、一方的な部分公開買い付けを全会一致で退ける
19/1/202406:54BWSinovac董事會一致反對Alternative Liquidity主動提出的部分公開收購方案
19/1/202406:47BWLe conseil d'administration de Sinovac rejette à l'unanimité..
19/1/202405:33BWDas Board of Directors von Sinovac lehnt einstimmig ein..
18/1/202423:13EDGAR2Form SC 14D9 - Solicitation, recommendation statements
18/1/202423:00BWSinovac Board of Directors Unanimously Rejects an..
09/1/202408:46EDGAR2Form SC TO-T - Tender offer statement by Third Party
04/12/202322:01EDGAR2Form SC 13D/A - General statement of acquisition of..
04/10/202300:39EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
15/9/202322:59EDGAR2Form SC 13D/A - General statement of acquisition of..
12/9/202320:10BWシノバック、新型コロナウイルスに対するSA55抗体注射剤の臨床試験について進展を報告
12/9/202300:36BWSINOVAC informiert über die Fortschritte bei der klinischen..
11/9/202320:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/9/202319:55BWSINOVAC Reports on the Clinical Trial Progress of its..
06/9/202321:35BWシノバック取締役会、同意なき株式の部分公開買付を全会一致で拒否
06/9/202302:16BWSinovac-Vorstand lehnt ein unangefordertes..
06/9/202301:36BWLe conseil d’administration de Sinovac rejette à l’unanimité..
05/9/202321:04EDGAR2Form SC 14D9 - Solicitation, recommendation statements
05/9/202318:12BWSinovac Board of Directors Unanimously Rejects an..
30/8/202303:08BWシノバック、部分的な株式公開買付を一方的に受けたことを確認
29/8/202323:04BWSinovac bestätigt den Erhalt eines unangeforderten..
29/8/202320:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/8/202320:05BWSinovac confirme la réception d'une offre publique d’achat..
29/8/202317:07BWSinovac Confirms Receipt of an Unsolicited Partial Tender..
29/8/202305:40BWシノバック、子会社の法定代理人変更を発表
29/8/202303:19BWSinovac meldet Wechsel des rechtlichen Vertreters von..
29/8/202301:57BWSinovac annonce un changement au niveau du représentant..
28/8/202323:12EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/8/202321:44BWSinovac Announces Change of Legal Representative of Sinovac..
15/8/202320:27EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/8/202320:00BWSINOVAC Reports Unaudited First Half of 2023 Financial..
13/5/202302:22BWCoronaVac® von SINOVAC erfüllt Hongkongs Bedarf an..
11/5/202304:02BWシノバックのCoronaVac ®、香港において自己負担でCOVID-19ワクチンを受ける人々のニーズに対応
10/5/202319:51BWSINOVAC’s CoronaVac® Answers Hong Kong’s Need for Self-Pay..
01/5/202320:00BWSINOVAC Reports Unaudited Second Half of 2022 Financial..

Your Recent History

Delayed Upgrade Clock